Acme Therapeutics (I) Private Limited

Acme Therapeutics (I) Private Limited - pharma in Panchkula, Haryana, India. FY 2026 financials and compliance.
CIN U24232HR2001PTC093261 Incorporated 14 March 2001 ROC Delhi HQ Panchkula, Haryana, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹14.81 Cr
▼ 8.00% YoY
EBITDA · FY 2025
Locked
In full report
Net profit · FY 2025
Locked
In full report
Authorised capital
₹18 Lakh
Registered with MCA
Paid-up capital
₹16.23 Lakh
Issued & subscribed
Open charges
₹4.25 Cr
Satisfied ₹1.6 Cr
Company age
25 yrs
Est. 2001
Employees · EPFO
302
Latest available

About Acme Therapeutics (I) Private Limited

Data last updated: 10 January 2026

Acme Therapeutics (I) Private Limited is a private limited company based in Panchkula, Haryana, India. It specialises in pharmaceutical retail and distribution, a part of the broader pharmaceuticals sector. Incorporated on 14 March 2001, the company has been in operation for over 25 years.

Registered with ROC Delhi under CIN U24232HR2001PTC093261.

Capital: an authorised share capital of ₹18 Lakh and a paid-up capital of ₹16.23 Lakh. Formerly known as Acme Therapeutics Private Limited and Acme Pharmaceuticals Private Limited. It is led by directors including Banshidhar Kanhaiyalal and Gopal Krishna.

Last AGM: 27 September 2025. Financial statements filed for year ended 31 March 2025. Office: Flat No 1601 Tower 7A Suncity Parikrama Sector 20, Panchkula, Haryana, India – 134109.

As per the financials filed for FY 2025, the company reported a revenue of ₹14.81 Cr, a decline of 8% compared to the previous year.

The company has a workforce of approximately 302 employees as per the latest available data.

As per MCA filings, the company has open charges of ₹4.25 Cr and satisfied charges of ₹1.6 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website atipl.in.

Company Details of Acme Therapeutics (I) Private Limited
CIN U24232HR2001PTC093261
Registration Number 093261
Incorporation Date 14 March 2001
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 27 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
  • Social Media
  • Registered Address
    Flat No 1601 Tower 7A Suncity Parikrama Sector 20, Panchkula, Haryana, India – 134109
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors
Company report
Acme Therapeutics (I) Private Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Acme Therapeutics (I) Private Limited report

Financials, compliance, directors, charges, ownership and filings for Acme Therapeutics (I) Private Limited in one report.

10-year financials Directors & ownership Charges & compliance

Name History of Acme Therapeutics (I) Private Limited

Acme Therapeutics (I) Private Limited has undergone 2 name changes throughout its history. The company was previously known as Acme Therapeutics Private Limited, and Acme Pharmaceuticals Private Limited. The current legal name is Acme Therapeutics (I) Private Limited, reflecting the company's evolution and rebranding over time.

Company Name Status
Acme Therapeutics (I) Private Limited Current
Acme Therapeutics Private Limited Previous
Acme Pharmaceuticals Private Limited Previous

CIN History of Acme Therapeutics (I) Private Limited

Acme Therapeutics (I) Private Limited has one previous CIN (Corporate Identification Number): U24232MP2001PTC014592. The current CIN is U24232HR2001PTC093261, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
U24232HR2001PTC093261 Current
U24232MP2001PTC014592 Previous

Business Activity of Acme Therapeutics (I) Private Limited

Acme Therapeutics (I) Private Limited is engaged in the principal business activity of trade, with detailed activities including wholesale trading.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
G Trade G1 Wholesale Trading Locked
Premium access

Business activity turnover details for Acme Therapeutics (I) Private Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Acme Therapeutics (I) Private Limited

Acme Therapeutics (I) Private Limited is audited by N.K.DAFRIA & CO. for the financial year 2022. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
N.K.DAFRIA & CO. Locked Locked Locked
Premium access

Complete auditor history for Acme Therapeutics (I) Private Limited

Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Acme Therapeutics (I) Private Limited

Acme Therapeutics (I) Private Limited is currently managed by 3 directors, with 4 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Banshidhar Kanhaiyalal Director 14 Mar 2001 25 Years 5 Months Current
Gopal Krishna Director 01 May 2002 24 Years 3 Months Current
Sanjay Kumar Director 21 Oct 2019 6 Years 9 Months Current

Financials of Acme Therapeutics (I) Private Limited FY 2025 filings available

Acme Therapeutics (I) Private Limited reported revenue of ₹14.81 Cr (down 8.00% YoY) for FY 2025.

Revenue · FY 2025
₹14.81 Cr ▼ 8.00%
Premium access

Ten-year financial statements for Acme Therapeutics (I) Private Limited

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Acme Therapeutics (I) Private Limited

Premium access

Shareholding and ownership data for Acme Therapeutics (I) Private Limited

Promoter, institutional, public, and beneficial ownership values require an active report plan.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Acme Therapeutics (I) Private Limited

Open charges
₹4.25 Cr
Satisfied charges
₹1.6 Cr
Breakdown by lending institutions
Hdfc Bank Limited₹2.75 Cr
Others₹1.50 Cr
Latest charge details
DateLenderAmountStatus
27 Jan 2025 Hdfc Bank Limited ₹2.75 Cr Open
13 Feb 2024 Others ₹1.5 Cr Open
20 Mar 2020 Others ₹83.25 Lakh Satisfied
10 Dec 2015 Kotak Mahindra Bank Limited ₹42 Lakh Satisfied
03 Jun 2004 Punjab National Bank ₹35 Lakh Satisfied

Total charge records: 5 View all charges

Employees and EPFO Compliance at Acme Therapeutics (I) Private Limited

Acme Therapeutics (I) Private Limited has a workforce of 302 employees as of Apr 06, 2024.

Employee count
302
Active EPFO establishments
1
Employee growth
4.86%
Premium access

Employee and EPFO history for Acme Therapeutics (I) Private Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Acme Therapeutics (I) Private Limited

Premium access

GST registrations and filing compliance for Acme Therapeutics (I) Private Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Acme Therapeutics (I) Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Acme Therapeutics (I) Private Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Acme Therapeutics (I) Private Limited

Premium access

MSME payment history for Acme Therapeutics (I) Private Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Acme Therapeutics (I) Private Limited

Premium access

Corporate group structure for Acme Therapeutics (I) Private Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Acme Therapeutics (I) Private Limited

Premium access

MCA filings and documents for Acme Therapeutics (I) Private Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Acme Therapeutics (I) Private Limited

Charges
19 Nov 2025
A charge registered on 20 Mar 2020 via Charge ID 100341247 with Others was fully satisfied on 19 Nov 2025.
Activity
27 Sep 2025
Acme Therapeutics (I) Private Limited last Annual general meeting of members was held on 27 Sep 2025 as per latest MCA records.
Activity
31 Mar 2025
Acme Therapeutics (I) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Charges
27 Jan 2025
A charge with Hdfc Bank Limited amounted to Rs. 275.00 Lakh with Charge ID 101049295 was registered on 27 Jan 2025.
Charges
13 Feb 2024
A charge with Others amounted to Rs. 150.00 Lakh with Charge ID 100875794 was registered on 13 Feb 2024.
Charges
20 Mar 2020
A charge with Others amounted to Rs. 83.25 Lakh with Charge ID 100341247 was registered on 20 Mar 2020.

Frequently Asked Questions about Acme Therapeutics (I) Private Limited

Acme Therapeutics (I) Private Limited is an active private limited company in the pharma sector based in Panchkula, Haryana, India. It was incorporated on 14 March 2001 (25+ years old) and is registered under CIN U24232HR2001PTC093261. The company has 302 employees.

Acme Therapeutics (I) Private Limited reported revenue of ₹14.81 Cr for FY 2025 (down 8.00% YoY).

The current directors of Acme Therapeutics (I) Private Limited are:

The primary industry of Acme Therapeutics (I) Private Limited is pharma. The company specifically operates in pharmaceutical retailers and distributors. The company is currently active in this sector.

Acme Therapeutics (I) Private Limited can be reached at the registered office: Flat No 1601 Tower 7A Suncity Parikrama Sector 20, Panchkula, Haryana, India – 134109, or through the website atipl.in.

The authorised capital is ₹18 Lakh, and the paid-up capital is ₹16.23 Lakh.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available